Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, July 22, 2020
Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa's Second COVID-19 Therapeutic Development Program
Thursday, July 9, 2020
Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award
Tuesday, June 9, 2020
TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020
Thursday, April 9, 2020
Australian CRO Avance Clinical Designated an Essential Service as Strong Demand from Sponsors Continues Amid COVID-19 Crisis
Thursday, April 2, 2020
Avance Clinical on Top Reasons APAC Biotech Clients Choose Australia for Clinical Trials
Friday, March 20, 2020
Australian CRO, Avance Clinical is Uniquely Positioned for COVID-19 Vaccines and Therapies Clinical Trials

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: